Mercia Asset Management sells The Native Antigen Company holding
Mercia Asset Management has announced the sale of The Native Antigen Company Limited (NAC) to LGC, a specialist in the life sciences tools sector, for a total cash consideration of up to GBP18.0million.Mercia held a 29.4 per cent fully diluted direct holding in NAC at the date of sale and
